Skip to Content

Polynovo Ltd CALZF Stock Quote

| Rating as of

Morningstar‘s Stock Analysis CALZF

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics CALZF

Company Profile CALZF

Business Description

Polynovo Ltd develops innovative medical devices for several medical applications, utilizing the patented biodegradable polymer technology NovoSorb. NovoSorb is a family of proprietary medical-grade polymers that can be utilized to manufacture novel medical devices designed to support tissue repair and which then degrade in a defined fashion in-situ to harmless by-products. The company earns a maximum from the United States of America.

320 Lorimer Street, Unit 2
Port Melbourne, VIC, 3207, Australia
T +61 386814050
Industry Medical Devices
Most Recent Earnings
Fiscal Year End Jun 30, 2022
Stock Type Classic Growth
Employees 8